Equate Yeast Relief

Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur

Wal-mart Stores Inc
Human Otc Drug
NDC 79903-094

Equate Yeast Relief also known as Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur is a human otc drug labeled by 'Wal-mart Stores Inc'. National Drug Code (NDC) number for Equate Yeast Relief is 79903-094. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Equate Yeast Relief drug includes Candida Albicans - 30 [hp_X]/1 Sodium Chloride - 12 [hp_X]/1 Sulfur - 12 [hp_X]/1 Wood Creosote - 30 [hp_X]/1 . The currest status of Equate Yeast Relief drug is Active.

Drug Information:

Drug NDC:	79903-094
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Equate Yeast Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Wal-mart Stores Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	CANDIDA ALBICANS - 30 [hp_X]/1 SODIUM CHLORIDE - 12 [hp_X]/1 SULFUR - 12 [hp_X]/1 WOOD CREOSOTE - 30 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	04 Mar, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	WAL-MART STORES INC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0681131449076
UPC stands for Universal Product Code.
NUI:	N0000185372 N0000175629 N0000184306 N0000185001 M0008890 M0000728
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	4D7G21HDBC 451W47IQ8X 70FD1KFU70 3JYG22FD73
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Non-Standardized Fungal Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE] Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Fungal Proteins [CS] Allergens [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Cell-mediated Immunity [PE] Fungal Proteins [CS] Increased Histamine Release [PE] Increased IgG Production [PE] Non-Standardized Fungal Allergenic Extract [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
79903-094-14	60 BLISTER PACK in 1 BOX (79903-094-14) / 1 TABLET in 1 BLISTER PACK	04 Mar, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Equate Yeast Relief

Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur

Tablet
WAL-MART STORES INC
NDC: 79903-094

Azo Yeast Plus

Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur

Tablet
i-Health, Inc.
NDC: 49973-667

Homeopathic Medicine Yeast Relief Plus

Candida Albicans, Wood Creosote, Sodium Chloride, And Sulfur

Tablet
WALGREEN CO.
NDC: 0363-6500

Purpose:

Purpose candida albicans 30x - relief from vaginal itching, burning and discharge candida albicans 30x - relief from vaginal itching, burning, odor and discharge kreosotum 30x - relief from vaginal itching, burning, odor and discharge natrium muriaticum 12x - relief from vaginal itching, burning, odor and discharge sulphur 12x - relief from vaginal itching, burning, odor and discharge

Product Elements:

Equate yeast relief candida albicans, wood creosote, sodium chloride, and sulfur sucrose cellulose, microcrystalline magnesium stearate candida albicans candida albicans wood creosote wood creosote sodium chloride chloride ion sulfur sulfur h

Indications and Usage:

Uses see your doctor if this is the first time you have vaginal itching and discomfort to find out if you have a vaginal yeast infection. according to homeopathic indications, these ingredients provide temporary relief of yeast infection related symprtoms such as: itching and burning, occasional vaginal odor and discharge, after consultation by a physician. *these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Warnings:

Warnings for oral use only. this product will not cure a yeast infection. do not use if you have never had a vaginal yeast infection diagnosed by a doctor.

Dosage and Administration:

Directions adults: take one tablet orally three times a day as long as symptoms persist. children: consult a doctor prior to use. take at least 10 minutes before or at least 10 minutes after eating or drinking. for occasional support take one tablet per day. homeopathic remedies may not be effective for everyone. individual results may vary.

Stop Use:

Stop use and contact your physician if your symptoms do not improve within 3 days or if symptoms last more than 7 days. you get a rash, hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge.

Package Label Principal Display Panel:

Principal display panel carton

Further Questions:

Questions or comments quesitons? 1-888-287-1915

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.